Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

Input Agnostic Deep Learning for Alzheimer's Disease Classification Using Multimodal MRI Images

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Classification of Alzheimer’s disease using MRI data based on Deep Learning Techniques

Deep Convolutional Neural Network based Classification of Alzheimer's Disease using MRI data

3D CNN-based classification using sMRI and MD-DTI images for Alzheimer disease studies

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images

Multimodal deep learning for Alzheimer’s disease dementia assessment

Multimodal deep learning models for early detection of Alzheimer’s disease stage

Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer’s Disease Diagnosis

Multi input - Multi output 3D CNN for dementia severity assessment with incomplete multimodal data

A Novel Multimodal MRI Analysis for Alzheimer's Disease Based on Convolutional Neural Network

Multimodal Attention-based Deep Learning for Alzheimer's Disease Diagnosis

Development and validation of a deep learning framework for Alzheimer’s disease classification

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

Automated detection of Alzheimer's disease: a multi-modal approach with 3D MRI and amyloid PET

Dominating Alzheimer's disease diagnosis with deep learning on sMRI and DTI-MD

A Transfer Learning Approach for Early Diagnosis of Alzheimer’s Disease on MRI Images

Automatic Classification of Alzheimer's Disease using brain MRI data and deep Convolutional Neural Networks

Recognition of Alzheimer's disease and Mild Cognitive Impairment with multimodal image-derived biomarkers and Multiple Kernel Learning

CNNs Based Multi-Modality Classification for AD Diagnosis

A deep learning framework for early diagnosis of Alzheimer's disease on MRI images